Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. - ROEverified

TARS

Price:

$63.16

Market Cap:

$2.72B

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas...[Read more]

Industry

Biotechnology

IPO Date

2020-10-16

Stock Exchange

NASDAQ

Ticker

TARS

The ROE as of June 2026 (TTM) for Tarsus Pharmaceuticals, Inc. (TARS) is -14.19%

According to Tarsus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -14.19%. This represents a change of 296.90% compared to the average of -3.58% of the last 4 quarters.

Tarsus Pharmaceuticals, Inc. (TARS) Historical ROE (quarterly & annually)

How has TARS ROE performed in the past?

The mean historical ROE of Tarsus Pharmaceuticals, Inc. over the last ten years is -2.65%. The current -14.19% ROE has changed 434.65% with respect to the historical average. Over the past ten years (40 quarters), TARS's ROE was at its highest in in the September 2020 quarter at 56.86%. The ROE was at its lowest in in the June 2023 quarter at -21.27%.

Quarterly (TTM)
Annual

Average

-2.65%

Median

-17.75%

Minimum

-68.99%

Maximum

97.42%

Tarsus Pharmaceuticals, Inc. (TARS) ROE by Quarter and Year

Discovering the peaks and valleys of Tarsus Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 288.13%

Maximum Annual ROE = 97.42%

Minimum Annual Increase = -120.77%

Minimum Annual ROE = -68.99%

Quarterly (TTM)
Annual
YearROEChange
2025-19.34%-62.42%
2024-51.46%-25.40%
2023-68.99%114.32%
2022-32.19%288.13%
2021-8.29%-48.66%
2020-16.15%-120.77%
201977.77%-20.17%

Tarsus Pharmaceuticals, Inc. (TARS) Average ROE

How has TARS ROE performed in the past?

The current ROE of Tarsus Pharmaceuticals, Inc. (TARS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-46.60%

5-year avg

-36.05%

10-year avg

-2.65%

Tarsus Pharmaceuticals, Inc. (TARS) ROE vs. Peers

How is TARS’s ROE compared to its peers?

Tarsus Pharmaceuticals, Inc.’s ROE is greater than Disc Medicine, Inc. (-36.95%), greater than Legend Biotech Corporation (-24.91%), greater than Travere Therapeutics, Inc. (-26.79%), greater than Zai Lab Limited (-24.29%), greater than CG Oncology, Inc. Common stock (-23.33%), greater than Celcuity Inc. (-244.61%), greater than Scholar Rock Holding Corporation (-163.52%), greater than Arcutis Biotherapeutics, Inc. (-1.41%), greater than Adaptive Biotechnologies Corporation (-24.26%), greater than Ascentage Pharma Group International (-123.61%),

Build a custom stock screener for Tarsus Pharmaceuticals, Inc. (TARS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tarsus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tarsus Pharmaceuticals, Inc. (TARS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tarsus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Tarsus Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Tarsus Pharmaceuticals, Inc. (TARS)?

What is the highest ROE for Tarsus Pharmaceuticals, Inc. (TARS)?

What is the 3-year average ROE for Tarsus Pharmaceuticals, Inc. (TARS)?

What is the 5-year average ROE for Tarsus Pharmaceuticals, Inc. (TARS)?

How does the current ROE for Tarsus Pharmaceuticals, Inc. (TARS) compare to its historical average?